Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (421-430 of 662) with videos related to

Pageof 67
Sort By:
Ebiomedicine|September 22, 2016
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergyPetra Zieglmayer, Margarete Focke-Tejkl, René Schmutz, et al.
European Journal of Haematology|March 17, 2022
Multistep pathogenesis of chronic myelomonocytic leukemia in patientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based AnalysisJohannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 6, 2006
Allergen cleavage by effector cell-derived proteases regulates allergic inflammationIngrid Rauter, Maria-Theresa Krauth, Sabine Flicker, et al.
Blood|January 1, 2005
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotidesKarl J Aichberger, Matthias Mayerhofer, Maria-Theresa Krauth, et al.
Blood|May 29, 2010
Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformationKatrin Friedbichler, Marc A Kerenyi, Boris Kovacic, et al.
Blood|January 12, 2011
High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemiaWolfgang Warsch, Karoline Kollmann, Eva Eckelhart, et al.
British Journal of Haematology|September 17, 2013
A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemiaCarsten Müller-Tidow, Gesine Bug, Michael Lübbert, et al.
Blood|July 20, 2006
The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cellsKarl J Aichberger, Matthias Mayerhofer, Anja Vales, et al.
Journal of Leukocyte Biology|September 21, 2013
The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cellsBarbara Peter, Sabine Cerny-Reiterer, Emir Hadzijusufovic, et al.
Pageof 67

Showing results (421-430 of 662) with videos related to

Sort By:
Pageof 67
Ebiomedicine|September 22, 2016
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergyPetra Zieglmayer, Margarete Focke-Tejkl, René Schmutz, et al.
European Journal of Haematology|March 17, 2022
Multistep pathogenesis of chronic myelomonocytic leukemia in patientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based AnalysisJohannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 6, 2006
Allergen cleavage by effector cell-derived proteases regulates allergic inflammationIngrid Rauter, Maria-Theresa Krauth, Sabine Flicker, et al.
Blood|January 1, 2005
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotidesKarl J Aichberger, Matthias Mayerhofer, Maria-Theresa Krauth, et al.
Blood|May 29, 2010
Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformationKatrin Friedbichler, Marc A Kerenyi, Boris Kovacic, et al.
Blood|January 12, 2011
High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemiaWolfgang Warsch, Karoline Kollmann, Eva Eckelhart, et al.
British Journal of Haematology|September 17, 2013
A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemiaCarsten Müller-Tidow, Gesine Bug, Michael Lübbert, et al.
Blood|July 20, 2006
The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cellsKarl J Aichberger, Matthias Mayerhofer, Anja Vales, et al.
Journal of Leukocyte Biology|September 21, 2013
The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cellsBarbara Peter, Sabine Cerny-Reiterer, Emir Hadzijusufovic, et al.
Pageof 67